|

RAPA-201 Rapamycin Resistant T Cells Clinical Trials

1 actively recruiting trial across 1 location

Also known as: RAPA-201 cells

Pipeline

Phase 1/2: 1

Top Sponsors

  • Rapa Therapeutics LLC1

Indications

  • Squamous Cell Carcinoma of Other Specified Sites of Skin1
  • Squamous Cell Carcinoma of Nasopharynx1
  • Small Cell and Non-small Cell Lung Cancer1
  • Squamous Cell Carcinoma of Larynx1
  • Squamous Cell Carcinoma of Oral Cavity1

Hackensack, New Jersey1 trial

RAPA-201 Therapy of Solid Tumors

Hackensack University Medical Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.